Abstract: The present disclosure provides a device for controlling the shape of an aerosol particle condensation growth flow field through an electromagnetic field. The device includes an aerosol growth device and a power supply. The aerosol growth device includes a porous medium, magnetic rubber and an electromagnet group. The magnetic rubber is sleeved in an inner cavity of the electromagnet group, and the porous medium is sleeved in an inner cavity of the magnetic rubber. The magnetic rubber is clung or clings to the porous medium, and the power supply is connected with the electromagnet group. The present disclosure also provides a method for controlling the shape of the aerosol particle condensation growth flow field through the electromagnetic field.

Abstract: Provided in the present application are an antibody-drug conjugate, and a preparation method therefor and the use thereof. The antibody drug conjugate has a structure as represented by the formula Ab-[M-L-E-D]x, and the drug is selected from an anti-tubulin agent, a DNA intercalator, a DNA topoisomerase inhibitor and a RNA polymerase inhibitor. The prepared antibody-drug conjugate has a better drug-to-antibody ratio, and has a good targeted killing effect on colon cancer and non-small cell lung cancer (for example, lung adenocarcinoma).

Abstract: The present invention relates to a chemical coupling linker and use thereof, and a bioactive conjugate prepared by the chemical coupling linker. The present invention also relates to use of the bioactive conjugate in the preparation of a drug for the prevention or treatment of tumor diseases.

Abstract: The present invention relates to a Camptothecin compound having anti-tumor activity, a preparation method therefor, and an application thereof. Specifically, the present invention relates to a compound as shown below or a pharmaceutically acceptable form thereof, a pharmaceutical composition thereof, a preparation method therefor, and a use thereof.

Abstract: The present invention relates to a pyrazole compound and a preparation method therefor and a use thereof. In particular, the present invention relates to a compound shown in Formula I, a pharmaceutical composition containing same or a pharmaceutically acceptable form thereof, a pharmaceutical composition thereof, a preparation method therefor, and a use thereof.

Abstract: Reactor configurations may include one or more staged inlets and/or one or more staged outlets for gaseous and solid feedstocks. In one embodiment of the present disclosure, a reactor design for gas-solid reaction with one or more additional outlet for gas and/or solid phase is provided. In yet another embodiment, the design for a gas-solid reactor with one side inlet and two outlets for gas phase is described. In one embodiment, a reactor design with pairs of inlet and outlet for both gas and solid phase is provided. In another embodiment, a reactor design with one or more side inlets but only one outlet for gas phase is provided. In yet another embodiment, a reactor design with two inlets at the top/bottom of reactor and two side outlets for gaseous phase is described. In yet another embodiment, a reactor design with one or more side inlets and outlets for both gas and solid phases is provided.

Abstract: The present disclosure provides a device for controlling the shape of an aerosol particle condensation growth flow field through an electromagnetic field. The device includes an aerosol growth device and a power supply. The aerosol growth device includes a porous medium, magnetic rubber and an electromagnet group. The magnetic rubber is sleeved in an inner cavity of the electromagnet group, and the porous medium is sleeved in an inner cavity of the magnetic rubber. The magnetic rubber is clung or clings to the porous medium, and the power supply is connected with the electromagnet group. The present disclosure also provides a method for controlling the shape of the aerosol particle condensation growth flow field through the electromagnetic field.

Abstract: Provided in the present invention are a compound of Formula (I), a pharmaceutical composition comprising the same, a method for preparing the same, and use thereof as a NS5B polymerase inhibitor, a DNA polymerase inhibitor or a reverse transcriptase inhibitor for the prevention or treatment of viral diseases or cancers.

Abstract: Provided in the present invention are a compound of Formula (I), a pharmaceutical composition comprising the same, a method for preparing the same, and use thereof as a NS5B polymerase inhibitor, a DNA polymerase inhibitor or a reverse transcriptase inhibitor for the prevention or treatment of viral diseases or cancers.

Abstract: The invention relates to aza-amino acid backbone-modified biomimetic collagens and general methods for designing and making biomimetic materials and molecular mimics.

Abstract: The present application relates to DDR connectors, particularly to a new DDR socket connector. The DDR socket connector comprises two fastening posts, an insert and a plugging groove. Each of the fastening posts are made of plastic and located at two sides of the groove. The insert is embedded in one of the two fastening posts and made of metal, and the insert includes a main body and two side parts. The main body is located in the middle portion of the insert, and the side parts are located at two sides of the main body. Compared with the prior art, the beneficial effects of the present application lie in: the plastic connecting part is inserted with a metal insert to overcome such deficiencies as plastic getting weak when being heated and thus eliminate the adverse impact of high temperature on the product.

Abstract: The invention relates to aza-amino acid backbone-modified biomimetic collagens and general methods for designing and making biomimetic materials and molecular mimics.

Abstract: The present invention generally concerns a method and a system for providing a computer-generated response in response to natural language inputs. The response includes, but is not limited to, visual, audio, and textual forms. The response is capable of being displayed or shown in a visual 2- or 3-dimensional virtual world. In one aspect, the present invention provides a method of providing a computer-generated response, including the steps of (i) receiving a computer-recognisable input originating from a user of a computer-simulated environment for facilitating interaction between the user and a simulated character controlled by a controller, (ii) extracting input information from the computer-recognisable input as extracted input information at least partly by linguistic analysis or semantic analysis and (iii) causing an action to be generated in response to the computer-recognisable input based at least partly on the extracted input information.